Peroxisome proliferators (PPs) are a group of structurally diverse compounds that are extensively used by humans, even though they cause increases in peroxisomes, hepatocellular proliferation and liver cancer in rodents. It was recently shown that free radicals play a central role in signaling in Kupffer cells, which produce mitogens (e.g., TNFalpha) and trigger cell proliferation in response to PPs; still, whether an increase in oxidants leads to DNA damage, thus contributing to carcinogenesis is not proven. It is hypothesized that PPs cause formation of oxidative DNA adducts and induce repair of these lesions. In addition, we will test whether the ability to induce DNA damage and/or repair correlates with carcinogenic potency of these compounds. Both potent (i.e., WY-14,643, and gemfibrozil) and weak (i.e., diethylhexyl and di-isononyl phthalates) rodent carcinogens, which are critical for human risk assessment will be studied. First, taking advantage of recent improvements in analytical technology and carefully avoiding artifactual adduct formation, we will look at the number of DNA lesions known to result from oxidative stress (e.g., 8-oxo-deoxyguanosine, etheno DNA adducts, apurinic/apyrimidinic sites). Second, we will investigate whether DNA repair enzymes, a response to DNA damage, are increased by PPs and whether DNA repair mechanisms are in balance using recently developed assay for abasic sites. Finally, using key knockout mouse strains (i.e., PPARalpha and NADPH oxidase-deficient p47phox) we will explore whether Kupffer cells or peroxisomes in hepatocytes are the source of oxidants for DNA adduct formation. Collectively, these studies will fill critical gaps in our knowledge regarding the mechanisms of action of this class of compounds and will have important implications for mechanistically based risk assessment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32ES005920-02
Application #
6382119
Study Section
Special Emphasis Panel (ZRG1-ET-1 (01))
Program Officer
Shreffler, Carol K
Project Start
2001-07-01
Project End
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
2
Fiscal Year
2001
Total Cost
$49,412
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599